Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Drug Development

      Johnson & Johnson moves up COVID-19 vaccine trial to second half of July

      Clinical Trials
      Johnson & Johnson announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of...

      Kite Receives European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe

      FDA Approvals
      Kite, a Gilead Company announced it has received approval to implement a variation to the Yescarta® (axicabtagene ciloleucel) Marketing Authorization from the EMA for...

      Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19

      Drug Development
      Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,...

      Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment

      Clinical Trials
      Eli Lilly and Company announced its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment...

      Sun Pharma initiates Phase-II clinical trial on AQCH for treatment of COVID-19 patients

      Asia
      Sun Pharmaceutical Industries Ltd. announced that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatment of COVID-19....

      AI to deliver next evolution of drug manufacturing and supply chain efficiency

      Drug Development
      In the absence of ‘in person’ meetings, access to deep dive pharma insights are not on hold, and later this month experts will discuss...

      FDA Approves Merck’s RECARBRIO for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

      FDA Approvals
      Merck, known as MSD outside the United States and Canada, announced that the U.S. FDA has approved a supplemental New Drug Application (sNDA) for...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.